- Business
-
Marketing & Advertising
Featured Story
Glaxo Hit the Most By Drug Price Control Order
HYDERABAD, India, May 20, 2013 (DNA : DAILY NEWS & ANALYSIS (INDIA)) - Consumers may celebrate the new drug price control order (DPCO), which was...
-
R&D
Featured Story
XenoPort Phase III MS Drug Misses Endpoint
XenoPort Reports Top-Line Results of Phase 3 Trial of Arbaclofen Placarbil for Spasticity in Multiple Sclerosis Patients SANTA CLARA, Calif. --(...
-
Therapeutics
Featured Story
FDA OKs Simponi for Ulcerative Colitis Indication
Simponi has already been approved by the FDA for the treatment of moderately to severely active rheumatoid arthritis
-
Pharmalot
Featured Story
Bristol-Myers Is Fined For Monkey Deaths, But Will $2,600 Matter?
In what is apparently an unusual move, the US Department of Agriculture earlier this year fined Bristol-Myers Squibb for violating the Animal Welfare...
- Resources
- Directories
- Manny Awards
- Events
- Jobs
